2025 Cherry Blossom Allergy Conference (CBAC)

Washington, DC US
March 28, 2025 to March 30, 2025

image

Don’t miss this exciting opportunity to be part of the 1st Annual Cherry Blossom Allergy Conference that will take place March 28-30, 2025, at the InterContinental The Wharf in Washington D.C. This 3-day CME program – developed by the American College of Allergy, Asthma & Immunology (ACAAI), along with Dr. Rachel Schreiber and Dr. Kristin Sokol – will highlight new insights into the diagnosis, evaluation and treatment of various allergic and immunologic conditions, with an attention to real-world clinical application. 

Sessions are designed to be engaging, interactive, and fun. Panel discussions will take place, highlighting the most up-to-date evidence and therapeutics for the diseases we see daily. Attendees will hear from experts not only in the specialty of allergy/immunology, but also from experts in the fields of pulmonology, otolaryngology, and dermatology, who will offer insight and perspective regarding new paradigms of care. 

In addition, this will be a family affair! Plan to bring your family to the nation’s capital at the most gorgeous time of the year – cherry blossom season. We will have a welcome dinner on Friday night, and our Saturday and Sunday sessions will be scheduled to allow for family time in the afternoons. A free shuttle from the Intercontinental Wharf at the waterfront will transport you to some of the top attractions in DC, including the National Mall (near the Smithsonian Air and Space Museum and the Smithsonian National Museum of Natural History), L’Enfant Plaza (near the Spy Museum), and the Duck Pond.

Make plans now to join us in DC during cherry blossom season! 

REGISTRATION FEE
$250/attendee
Free for students, residents and FITs (College membership is free for Fellows-in-Training)

GUEST FEE
$50/guest to attend Friday's Welcome Dinner (children 0-12 years old FREE)

Please see Venue tab for hotel accommodation details.

REFUNDS/CANCELLATIONS
Refunds, cancellations, and changes are available (minus $75 administration fee) if your request is received via email (katyallen@acaai.org) on or before March 10, 2025. Cancellation requests received after March 10, 2025 are not eligible for a refund.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunology and the Cherry Blossom Allergy Conference (CBAC). The American College of Allergy, Asthma & Immunology is accredited by the ACCME to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Practicing allergists
Allied health professionals

Learning Objectives

At the conclusion of this activity, learners should be able to…
1. Identify IgE-mediated vs. non-IgE mediated adverse reactions to drugs, and then utilize appropriate testing in the evaluation of drug allergy in a clinic setting. 
2. Complete a comprehensive work-up for eosinophilia. 
3. Identify asthma mimickers through a comprehensive history and evaluation. 
4. Engage patients in shared decision-making processes, taking into account patient preferences, concerns, and circumstances when prescribing epinephrine.
5. Identify new delivery devices of epinephrine. 
6. Understand the pathophysiology of chronic rhinosinusitis with nasal polyps, and examine the differences in treatment for this disease from an ENT and allergist perspective. 
7. Diagnose secondary immunodeficiencies. 
8. Evaluate primary immunodeficiencies in a step-wise fashion. 
9. Test and treat venom anaphylaxis. 
10. Summarize the common causes of chronic cough. 
11. Identify the correct biologic medication for specific allergic conditions and learn about new/emerging biologic therapies. 

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
  
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships with ineligible companies have been mitigated.

Course summary
Available credit: 
  • 8.25 AMA PRA Category 1 Credit™
  • 8.25 Attendance
Course opens: 
10/16/2024
Course expires: 
12/31/2026
Event starts: 
03/28/2025 - 3:00pm CDT
Event ends: 
03/30/2025 - 2:00pm CDT
Cost:
$250.00
Add to calendar: 
Rating: 
0
Cherry Blossom Allergy Conference Agenda 
March 28 - 30, 2025
Intercontinental Wharf D.C.

Tentative Agenda

Friday March 28th 
6:30 pm Welcome Dinner
Intercontinental Wharf D.C. (Families Invited) 

Saturday March 29th 
7:00 am – 7:55 am Sponsored Non-CME Breakfast Presentation 

7:55 am – 8:25 am Visit Exhibitors 

8:25 am – 8:30 am Welcome Remarks
Rachel Schreiber, MD and Kristin Sokol, MD

8:30 am – 9:10 am Drug Allergy: Real World Protocols in the Clinic Setting, Allison Ramsey, MD 
9:10 am – 9:15 am Q&A 

9:15 am – 9:55 am Eosinophilia: Diagnostic Strategies and Evaluation, Paneez Khoury, MD
9:55 am – 10:00 am Q&A 

10:00 am – 10:40 am The Role of Drugs and Disease in Secondary Immunodeficiencies, Antoine Azar, MD
10:40 am – 10:45 am Q&A

10:45 am - 11:15 am Refreshment Break 

11:15 am – 12:05 pm Panel Discussion - Practical approach to Eosinophils in CRSwNP- Collaboration Between ENT and Allergist-Immunologists
Paneez Khoury, MD: Joshua Levy, MD; David Schwartz, MD
12:05 pm – 12:15 pm Q&A 

12:15 pm – 1:05 pm Panel Discussion - Anaphylaxis: Mimickers, Shared Decision Making and Treatment
David Golden, MD; Andrej Petrov, MD; Shahzad Mustafa, MD
1:05 pm – 1:15 pm Q&A
 
1:15 pm – 2:00 pm Lunch

Afternoon on own 

Sunday March 30th 
7:00 am – 7:55 am Sponsored Non-CME Breakfast Presentation 

7:55 am – 8:25 am Visit Exhibitors 

8:30 am – 9:05 am Exertional Dyspnea - What an Allergist Needs to Know, Andrej Petrov, MD
9:05 am – 9:15 am Q&A 

9:15 am – 9:50 am Diagnosing Primary Immunodeficiency: Best Practices in a Clinical Setting, Shahzad Mustafa, MD
9:50 am – 10:00 am Q&A 

10:00 am – 10:40 am Venom-Induced Anaphylaxis: Diagnosis and Care Protocols, David Golden, MD 
10:40 am – 10:45 am Q&A

10:45 am – 11:15 am Morning Refreshment Break 

11:15 am – 11:55 am Panel Discussion - Chronic Cough: Challenging Cases and Expert Analysis
Antoine Azar, MD; Andrej Petrov, MD
11:55 am – 12:00 pm Q&A 

12:00 pm – 12:50 pm Panel Discussion - Advancements in Biologics for Allergy Care: A Look Ahead
Andrej Petrov MD; Allison Ramsey, MD; Shahzad Mustafa, MD
12:50 pm – 1:00 pm Q&A 

1:00 pm - 1:05 pm Closing Remarks 
Rachel Schreiber, MD and Kristin Sokol, MD

InterContinenal Washington DC - The Wharf
801 Wharf St SW
Washington, DC 20024
United States
+1 (202) 878-8586

Hotel Room Rate & Resort Fee:  $399 Single / Double + 13% tax and a Resort Fee of $35 / night
Hotel cancellation policy: Cancellation: Guests must cancel their reservations (48) hours prior to arrival, or the first night’s room and tax will be charged

To make reservations online, click HERE

To make reservations by phone, please call: 202-878-8586
For questions about Room Reservations, please contact:
Reservations Team: washcreservations@ihg.com
Shengyl Poshka, Group Reservations Coordinator: shengyl.poshka@ihg.com 

The deadline for hotel reservations is Wednesday, February 26, 2025    

The Intercontinental at The Wharf DC is perfectly placed on the beautiful Potomac River. The Wharf enjoys the most incredible waterfront views of D.C. Steps away from America’s political epicenter, the hotel embraces guests with an exquisitely curated resort destination that reignites the river’s edge. The Wharf has immediate access to major roadways, is blocks away from public transit stops, and a short five miles away from the Reagan National Airport. The Wharf has free neighborhood shuttle service, and they have a roundtrip shuttle route to the National Mall. Each room at the InterContinental includes a Nespresso machine, a hot water kettle, an executive Desk with ample space for working, a refreshment bar and an in-room safe. In addition, there is a complimentary morning newspaper, complimentary overnight shoeshine and 24-hour in-room dining.

All relevant financial relationships with ineligible companies have been mitigated.

Rachel Schreiber, MD, Planner
Advisor: Novartis

Kristen Sokol, MD, Planner
Advisor: Novartis

Antoine Azar, MD, Speaker
Consultant: ADMA Biologics
Advisor: CSL Behring, Grifols, Takeda
Researcher: Grifols

David Golden, MD, Speaker
Consultant: Aquestive, Novartis, Kokua, Celldex,
Speaker: ThermoFischer
Independent Contractor: Genentech, Pfizer, Eli Lilly, Regeneron, GSK, Merck, Teva, AstraZeneca, Allergy Therapeutics, Sanofi

Paneez Khoury, MD. Speaker
Royalites/Patent: UpToDate

Joshua Levy, MD, Speaker

Shahzad Mustafa, MD, Speaker
Speaker: Genentech, Sanofi/Regeneron, GSK, AstraZeneca, CSL Behring

Andrej Petrov, MD, Speaker

Allison Ramsey, MD, Speaker
Speaker: GSK, Sanofi/Regeneron, AstraZeneca

David Schwartz, MD, Speaker

Available Credit

  • 8.25 AMA PRA Category 1 Credit™
  • 8.25 Attendance

Price

Cost:
$250.00
Please login or create an account to take this course.

Guests are welcome to attend Friday's Welcome Dinner!
Add a guest to your registration, $50 per guest (children 0-12 years old FREE)
Please include first and last name of guest(s) in the Order Comments during checkout.
If adding children ages 13-18, please include ages.